Sugi Predict

Sugi Predict / Compounds / SCHEMBL1312482

SCHEMBL1312482

SCHEMBL1312482

CCCCCCCCc1ccc(-c2ccc(N)cc2)cc1

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HTR2A P28223 1/20 0.68
▸ HSD17B10 Q99714 3/20 0.65
▸ ALDH1A1 P00352 3/20 0.65
▸ KDM4E B2RXH2 3/20 0.65
▸ MEN1 O00255 2/20 0.65
▸ MAPT P10636 2/20 0.65
▸ KMT2A Q03164 2/20 0.65
▸ RAB9A P51151 2/20 0.65
▸ USP2 O75604 1/20 0.65
▸ GAA P10253 1/20 0.65
▸ HPGD P15428 1/20 0.65
▸ SMN1; SMN2 Q16637 1/20 0.65
▸ TSHR P16473 1/20 0.61
▸ RARB P10826 5/20 0.59
▸ RARA P10276 1/20 0.59
▸ MTOR P42345 1/20 0.59
▸ ESR1 P03372 2/20 0.57
▸ ADRA2A P08913 2/20 0.57
▸ ADORA3 P0DMS8 2/20 0.57
▸ TACR2 P21452 2/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3700777 1.00 HTR2A (0.68) HTR2AHSD17B10ALDH1A1KDM4EMEN1
SCHEMBL10905830 1.00 HTR2A (0.68) HTR2AHSD17B10ALDH1A1KDM4EMEN1
SCHEMBL12293773 0.98 HTR2A (0.64) HTR2AHSD17B10ALDH1A1KDM4EMEN1
SCHEMBL353299 0.98 HTR2A (0.64) HTR2AHSD17B10ALDH1A1KDM4EMEN1
SCHEMBL25171839 0.94 HTR2A (0.76) HTR2AHSD17B10ALDH1A1KDM4EMEN1
SCHEMBL22346199 0.94 HTR2A (0.76) HTR2AHSD17B10ALDH1A1KDM4EMEN1
SCHEMBL22346250 0.94 HTR2A (0.76) HTR2AHSD17B10ALDH1A1KDM4EMEN1
SCHEMBL23754742 0.94 HTR2A (0.76) HTR2AHSD17B10ALDH1A1KDM4EMEN1
Pentadecane SCHEMBL22346204 0.94 HTR2A (0.76) HTR2AHSD17B10ALDH1A1KDM4EMEN1
Tridecane SCHEMBL22346186 0.94 HTR2A (0.76) HTR2AHSD17B10ALDH1A1KDM4EMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10205108-B2 Compound CAMBRIDGE DISPLAY TECHNOLOGY LIMITED (GB) 2019-02-12 — — US disclosed
US-10205108-B2 Compound CAMBRIDGE DISPLAY TECHNOLOGY LIMITED (GB) 2019-02-12 — — US disclosed
US-20170040556-A1 COMPOUND CAMBRIDGE DISPLAY TECHNOLOGY LIMITED (GB) 2017-02-09 — — US disclosed
US-20170040556-A1 COMPOUND CAMBRIDGE DISPLAY TECHNOLOGY LIMITED (GB) 2017-02-09 — — US disclosed
US-20170040556-A1 COMPOUND CAMBRIDGE DISPLAY TECHNOLOGY LIMITED (GB) 2017-02-09 — — US disclosed
US-20140077194-A1 COMPOUND CAMBRIDGE DISPLAY TECHNOLOGY LIMITED (GB) 2014-03-20 — — US disclosed
US-20140077194-A1 COMPOUND CAMBRIDGE DISPLAY TECHNOLOGY LIMITED (GB) 2014-03-20 — — US disclosed
CN-103270077-A MACROMOLECULAR COMPOUND AND ORGANIC EL ELEMENT USING SAME SUMITOMO CHEMICAL CO 2013-08-28 — — CN disclosed
CN-102531926-A Pyrene polymer and luminescent element made with same SUMITOMO CHEMICAL CO 2012-07-04 — — CN disclosed
CN-102516091-A Pyrene polymer and luminescent element made with the same SUMITOMO CHEMICAL CO 2012-06-27 — — CN disclosed
CN-101663345-B Pyrene polymer compound and light-emitting device using the same SUMITOMO CHEMICAL CO 2012-01-25 — — CN disclosed
US-20110275673-A1 INHIBITORS OF SPHINGOSINE KINASE 1 GENZYME CORPORATION 2011-11-10 — — US disclosed
WO-2011115611-A1 LIQUID CRYSTAL FORMULATIONS AND STRUCTURES FOR SMECTIC A OPTICAL DEVICES CAMBRIDGE ENTERPRISE LIMITED (GB) 2011-09-22 — — WO disclosed
US-7902363-B2 Novel air stable and solution processable n-type compounds such as n,n'-bis[3,7-dimethyl-6-octenyl]-1,7-dicyanoperylene-3,4:9,10-bis(dicarboxiamide); complementary circuits, organic light emitting diodes and photovoltaics, capacitors, sensors POLYERA CORPORATION (US) 2011-03-08 — — US disclosed
WO-2010033701-A2 INHIBITORS OF SPHINGOSINE KINASE 1 GENZYME CORPORATION (US) 2010-03-25 — — WO disclosed
CN-101663345-A Pyrene polymer compound and light-emitting device using the same SUMITOMO CHEMICAL CO 2010-03-03 — — CN disclosed
EP-2086974-A2 DIIMIDE-BASED SEMICONDUCTOR MATERIALS AND METHODS OF PREPARING AND USING THE SAME Polyera Corporation (US) 2009-08-12 — — EP disclosed
US-20080185577-A1 Diimide-based semiconductor materials and methods of preparing and using the same USINVEST LLC 2008-08-07 — — US disclosed
WO-2008063609-A2 DIIMIDE-BASED SEMICONDUCTOR MATERIALS AND METHODS OF PREPARING AND USING THE SAME POLYERA CORPORATION (US) 2008-05-29 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10205108-B2 Compound C5, CFB, C1S HTR2A 2186/4885HSD17B10 1563/4885ALDH1A1 1936/4885
US-20110275673-A1 INHIBITORS OF SPHINGOSINE KINASE 1 SPHK1, SPHK2, S1PR1 HTR2A 4137/4885HSD17B10 914/4885ALDH1A1 1495/4885
US-20080185577-A1 Diimide-based semiconductor materials and methods of preparing and using the same DDT, INMT, PIR HTR2A 2301/4885HSD17B10 3398/4885ALDH1A1 2611/4885
US-20170040556-A1 COMPOUND C5, CFB, C1S HTR2A 2186/4885HSD17B10 1563/4885ALDH1A1 1936/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.